Diagnostic Test Portfolio

About CheckMab

CheckMab is a private, pre-revenue biotech firm leveraging monoclonal antibody technology for diagnostic and therapeutic applications in oncology and autoimmunity. Founded in 2006 and headquartered in Siena, Italy, the company appears to be in the pre-clinical or early development stage, focusing on translating its antibody expertise into novel tests and potential therapies. Its strategy involves partnerships to advance its programs, targeting significant unmet medical needs in cancer and autoimmune disease diagnostics.

Therapeutic Areas

Other Autoimmune Diseases & Cancer Drugs